The FDA approved the making of a new COVID-19 vaccine that will be monovalent and targeting the Omicron subvariants. It is a new type of monovalent vaccine targeting just our most prevalent COVID variant; Omicron which is close to 60 % of our cases in Connecticut Continue Reading →








